Herpangina (Coxsackievirus Type A)
Overview
Plain-Language Overview
Herpangina (Coxsackievirus Type A) is a common viral infection that mainly affects the throat and mouth. It primarily occurs in children and causes small, painful sores or ulcers on the roof of the mouth and back of the throat. These sores can make swallowing and eating uncomfortable. The infection is caused by a virus from the enterovirus family, which spreads easily through saliva and respiratory droplets. Symptoms often include a sudden fever, sore throat, and difficulty swallowing. Although uncomfortable, the illness usually resolves on its own within a week without serious complications.
Clinical Definition
Herpangina is an acute, self-limited viral illness characterized by the development of multiple small vesicular lesions on the soft palate, uvula, and tonsillar pillars. It is most commonly caused by Coxsackievirus A serotypes, members of the enterovirus genus. The pathogenesis involves viral replication in the oropharyngeal mucosa leading to vesicle formation and ulceration. Clinically, it presents with sudden onset fever, odynophagia, and malaise, predominantly in children aged 3 to 10 years. The disease is highly contagious and spreads via the fecal-oral or respiratory route. Although generally benign, it is important to distinguish herpangina from other causes of oral ulcers and pharyngitis due to its characteristic lesion distribution and viral etiology.
Inciting Event
Ingestion or inhalation of virus-containing droplets or fecal matter initiates infection.
Exposure to contaminated surfaces or objects followed by hand-to-mouth contact triggers disease.
Close contact with a person actively shedding Coxsackievirus A initiates transmission.
Latency Period
The incubation period ranges from 3 to 6 days after viral exposure.
Symptoms typically develop within 4 to 7 days post-infection.
Diagnostic Delay
Early symptoms such as fever and sore throat are nonspecific and often mistaken for viral pharyngitis.
Lack of awareness of characteristic vesicular lesions on the soft palate delays diagnosis.
Mild or absent systemic symptoms in some cases lead to underrecognition.
Clinical Presentation
Signs & Symptoms
Sudden onset of high fever often preceding oral lesions by 1-2 days.
Sore throat and odynophagia due to painful vesicles in the oropharynx.
Small, painful vesicles and ulcers localized to the soft palate and tonsillar pillars.
Malaise, headache, and anorexia commonly accompany the illness.
Absence of significant respiratory symptoms or systemic toxicity.
History of Present Illness
Abrupt onset of high fever followed by sore throat and difficulty swallowing.
Development of multiple small vesicles and ulcers on the soft palate, tonsillar pillars, and uvula within 1-2 days of fever.
Associated symptoms include headache, malaise, and anorexia.
Symptoms typically resolve within 7 to 10 days without complications.
Past Medical History
No specific prior conditions are required but history of recent upper respiratory infections may be present.
Lack of prior immunization against enteroviruses does not prevent infection as no vaccine exists.
Previous episodes of herpangina or hand-foot-and-mouth disease may indicate susceptibility.
Family History
No known heritable genetic predisposition to herpangina.
Family members may have concurrent or recent enteroviral infections due to close contact.
No association with familial syndromes or inherited immunodeficiencies.
Physical Exam Findings
Multiple small, grayish-white vesicles on the soft palate, tonsillar pillars, and uvula surrounded by an erythematous halo.
Tender cervical lymphadenopathy may be present due to regional inflammation.
Mild pharyngeal erythema without significant tonsillar enlargement or exudate.
No significant respiratory distress or airway obstruction in typical cases.
Normal vital signs except for fever during the acute phase.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of herpangina is primarily clinical, based on the presence of multiple small vesicles or ulcers on the posterior oropharynx, especially the soft palate and tonsillar pillars, accompanied by acute onset fever and sore throat. Laboratory confirmation can be achieved by viral culture or PCR testing of throat swabs or stool samples identifying Coxsackievirus A. Differential diagnosis includes herpes simplex virus infection and hand-foot-and-mouth disease, which can be distinguished by lesion location and systemic symptoms. Serologic testing is rarely required but may support diagnosis in atypical cases.
Pathophysiology
Key Mechanisms
Enteroviral infection of the oropharyngeal mucosa by Coxsackievirus A leads to local viral replication and cytolysis.
Inflammatory response causes vesicular lesions and ulcerations on the soft palate, tonsillar pillars, and uvula.
Viral shedding in saliva and feces facilitates transmission and spread within the host.
Host immune activation results in systemic symptoms such as fever and malaise.
| Involvement | Details |
|---|---|
| Organs | Pharynx is the primary organ affected, presenting with vesicular ulcers on the soft palate and tonsillar pillars. |
Salivary glands may be involved, contributing to oral discomfort and altered saliva production. | |
| Tissues | Oropharyngeal mucosa is the site of vesicular lesion formation characteristic of herpangina. |
Lymphoid tissue in the oropharynx participates in immune response to Coxsackievirus infection. | |
| Cells | Epithelial cells of the oropharynx are the primary site of viral replication and lesion formation in herpangina. |
Macrophages participate in the innate immune response by phagocytosing infected cells and releasing cytokines. | |
T lymphocytes mediate adaptive immune clearance of infected cells during the course of infection. | |
| Chemical Mediators | Interleukin-1 (IL-1) is released by infected cells and macrophages, promoting fever and inflammation. |
Tumor necrosis factor-alpha (TNF-α) contributes to local tissue inflammation and systemic symptoms. | |
Prostaglandins mediate pain and fever associated with mucosal ulceration. |
Treatments
Pharmacological Treatments
Acetaminophen
- Mechanism:
Inhibits central prostaglandin synthesis to reduce fever and alleviate pain.
- Side effects:
Hepatotoxicity with overdose
Rare allergic reactions
- Clinical role:
First-line
Ibuprofen
- Mechanism:
Nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes, reducing inflammation, fever, and pain.
- Side effects:
Gastrointestinal irritation
Renal impairment
Increased bleeding risk
- Clinical role:
First-line
Topical oral anesthetics
- Mechanism:
Provide localized analgesia by blocking nerve conduction in oral mucosa.
- Side effects:
Local irritation
Rare allergic reactions
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Maintain adequate hydration with cool fluids to prevent dehydration from painful swallowing.
Provide soft, bland diet to minimize oral mucosa irritation during eating.
Ensure rest and supportive care to facilitate immune response and recovery.
Prevention
Pharmacological Prevention
No specific antiviral prophylaxis is available for herpangina.
No licensed vaccine currently exists against Coxsackievirus A.
Symptomatic treatment with analgesics and antipyretics is standard.
Non-pharmacological Prevention
Strict hand hygiene to reduce fecal-oral transmission of enteroviruses.
Avoidance of close contact with infected individuals during the contagious period.
Disinfection of contaminated surfaces and objects to prevent spread.
Isolation of affected children from group settings until fever and lesions resolve.
Outcome & Complications
Complications
Dehydration from painful swallowing leading to inadequate fluid intake.
Rare development of aseptic meningitis caused by enteroviral spread.
Secondary bacterial superinfection of oral lesions is uncommon but possible.
Very rare cases of myocarditis or pericarditis linked to enterovirus infection.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Herpangina (Coxsackievirus Type A) versus Herpes Simplex Virus (HSV) Gingivostomatitis
Herpangina (Coxsackievirus Type A) | Herpes Simplex Virus (HSV) Gingivostomatitis |
|---|---|
Vesicles and ulcers localized to the posterior oropharynx including soft palate and tonsillar pillars | Painful vesicles primarily on the anterior oral mucosa and lips |
Typically affects children aged 3 to 10 years | Commonly affects children aged 6 months to 5 years |
Moderate fever with minimal gingival involvement | High fever with prominent gingival inflammation and bleeding |
Herpangina (Coxsackievirus Type A) versus Hand, Foot, and Mouth Disease (Coxsackievirus A16 or Enterovirus 71)
Herpangina (Coxsackievirus Type A) | Hand, Foot, and Mouth Disease (Coxsackievirus A16 or Enterovirus 71) |
|---|---|
Vesicular lesions confined to the posterior oropharynx | Vesicular lesions on hands, feet, and oral mucosa |
Higher fever with sore throat and odynophagia | Mild fever with rash on extremities |
More common in summer months | Occurs year-round with peaks in summer and fall |
Herpangina (Coxsackievirus Type A) versus Acute Streptococcal Pharyngitis
Herpangina (Coxsackievirus Type A) | Acute Streptococcal Pharyngitis |
|---|---|
Presence of vesicular lesions and ulcers in the posterior oropharynx | Erythematous pharynx with tonsillar exudates but no vesicles |
Negative bacterial cultures; viral PCR may detect Coxsackievirus | Positive rapid antigen detection test or throat culture for Group A Streptococcus |
Supportive care only; no antibiotic benefit | Rapid improvement with beta-lactam antibiotics |
Herpangina (Coxsackievirus Type A) versus Infectious Mononucleosis
Herpangina (Coxsackievirus Type A) | Infectious Mononucleosis |
|---|---|
Shorter duration fever with localized oral lesions | Prolonged fever, fatigue, and lymphadenopathy |
Normal lymphocyte morphology and negative heterophile antibody | Atypical lymphocytosis and positive heterophile antibody test |
Vesicular lesions and ulcers in the posterior oropharynx | Pharyngeal erythema and exudates without vesicles |
Herpangina (Coxsackievirus Type A) versus Herpetic Whitlow
Herpangina (Coxsackievirus Type A) | Herpetic Whitlow |
|---|---|
Vesicular lesions confined to the oropharynx | Vesicular lesions on fingers or periungual area |
No finger involvement; oral exposure to Coxsackievirus | History of finger trauma or contact with HSV-infected secretions |
Systemic fever and sore throat | Localized pain and swelling without systemic fever |